Biocon Pharma Inc. drugs
17 results
Aminocaproic acid (aminocaproic acid)
(AMINOCAPROIC ACID)Biocon Pharma Inc.
Usage: Aminocaproic acid is indicated for enhancing hemostasis in scenarios where fibrinolysis causes bleeding, particularly after heart surgery, in hematological disorders, hepatic cirrhosis, and related neoplastic diseases. It is also used for excessive urinary tract bleeding following surgical or nonsurgical interventions.
Bioferr 90 (dual-iron)
(Dual-Iron)Biocon Pharma Inc.
Usage: BioFerr™ 90 is indicated for treating all anemias responsive to oral iron therapy, including hypochromic anemia related to pregnancy, blood loss (acute or chronic), metabolic diseases, post-surgical recovery, and dietary deficiencies.
Bupropion hydrochloride (bupropion hydrochloride)
(bupropion hydrochloride)Biocon Pharma Inc.
Usage: Bupropion hydrochloride extended-release tablets (XL) are indicated for treating major depressive disorder (MDD) and for preventing seasonal major depressive episodes in seasonal affective disorder (SAD). Efficacy was established through controlled trials for both conditions in adult patients.
Dasatinib (dasatinib)
(dasatinib)Biocon Pharma Inc.
Usage: Dasatinib is indicated for treating adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML) in chronic phase, Ph+ CML with resistance to prior therapy, and Ph+ acute lymphoblastic leukemia (ALL). It is also indicated for pediatric patients aged 1 and older with Ph+ CML and newly diagnosed Ph+ ALL.
Fingolimod (fingolimod)
(FINGOLIMOD)Biocon Pharma Inc.
Usage: Fingolimod capsules are indicated for treating relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients aged 10 years and older.
Hydrocortisone (hydrocortisone)
(Hydrocortisone)Biocon Pharma Inc.
Usage: Hydrocortisone Topical Solution 2.5% is indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions.
Lenalidomide (lenalidomide)
(Lenalidomide)Biocon Pharma Inc.
Usage: Lenalidomide is indicated for treating multiple myeloma (MM) in combination with dexamethasone, as maintenance therapy post-autologous stem cell transplantation, and for transfusion-dependent anemia due to myelodysplastic syndromes. It's also used for relapsed mantle cell lymphoma and in combination with rituximab for follicular and marginal zone lymphomas.
Mycophenolic acid (mycophenolic acid)
(Mycophenolic Acid)Biocon Pharma Inc.
Usage: Mycophenolic acid delayed-release tablets are indicated for the prophylaxis of organ rejection in adult and pediatric kidney transplant patients (5 years and older). They should be used alongside cyclosporine and corticosteroids, and not interchangeably with mycophenolate mofetil products without physician supervision.
Nitrofurantoin (nitrofurantoin)
(NITROFURANTOIN)Biocon Pharma Inc.
Usage: Nitrofurantoin oral suspension is indicated for treating urinary tract infections in adults and pediatric patients aged 1 month and older, caused by susceptible strains of various bacteria. It is not for pyelonephritis or perinephric abscesses and should be used to prevent drug-resistant bacteria.
Pemetrexed (pemetrexed disodium)
(Pemetrexed disodium)Biocon Pharma Inc.
Usage: Pemetrexed for injection is indicated for the treatment of metastatic and locally advanced non-squamous non-small cell lung cancer (NSCLC) in combination with specific chemotherapy or as a maintenance and single-agent treatment. It is also indicated, with cisplatin, for malignant pleural mesothelioma. Not for squamous cell NSCLC.